Company profile for Advanced Accelerator Applications

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Our work is guided by our commitment to bring new innovations to patients and AAA is dedicated to developing treatments for several leading types of cancer through the application of precision, targeted radioligand therapy. Our ambition is to leverage industry leading pipeline to unlock the benefit of radioligand therapy across different tumor types. Our goal is to reimagine nuclear medicine. All of our manufacturing facilitie...
Our work is guided by our commitment to bring new innovations to patients and AAA is dedicated to developing treatments for several leading types of cancer through the application of precision, targeted radioligand therapy. Our ambition is to leverage industry leading pipeline to unlock the benefit of radioligand therapy across different tumor types. Our goal is to reimagine nuclear medicine. All of our manufacturing facilities conform to current good manufacturing practices or cGMP. This network provides the basis for our advanced manufacturing capacity, cost-efficient production, and organization of reliable product distribution.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
France
Address
Address
20 Rue Diesel 01630 Saint-Genis-Pouilly
Telephone
Telephone
+33(0)450993070
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-23-2023-6184.pdf

FDA
23 Aug 2023
5 pharmas lambasted by UK watchdog for marketing snafus
5 pharmas lambasted by UK watchdog for marketing snafus

01 Aug 2022

// Ben Adams FIERCEPHARMA

https://www.fiercepharma.com/marketing/abbvie-allergan-advanced-accelerator-applications-otsuka-britannia-and-vifor-all-rapped

Ben Adams FIERCEPHARMA
01 Aug 2022

https://www.pharmacompass.com/pdf/news/advanced-accelerator-applications-usa-is-on-health-canada-inspection-list-1659337843.pdf

HEALTH CANADA
27 Jul 2022

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-13-2022-1649826529.pdf

FDA
13 Apr 2022

https://endpts.com/crinetics-spins-out-radiopharma-efforts-into-a-new-company-highlighting-the-growing-fields-allure/

Max Gelman ENDPTS
19 Oct 2021
Novartis backs up Endocyte buyout with prostate cancer data
Novartis backs up Endocyte buyout with prostate cancer data

04 Jun 2021

// Amirah Al Idrus FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/asco-novartis-backs-up-endocyte-buyout-prostate-cancer-data

Amirah Al Idrus FIERCE BIOTECH
04 Jun 2021

ABOUT THIS PAGE

Contact Advanced Accelerator Applications and get a quotation

Advanced Accelerator Applications is a supplier offers 3 products (APIs, Excipients or Intermediates).

Find a price of Lutetium Chloride Lu-177 bulk with DMF offered by Advanced Accelerator Applications

Find a price of Lysine Hydrochloride bulk offered by Advanced Accelerator Applications

Find a price of KIT FOR PREPARATION OF 99M TC-RHANNEXIN V-128 bulk offered by Advanced Accelerator Applications

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty